Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2015
Source ID
10.1016/j.neuroimage.2014.11.055

Entities

People

  • Andreas Delker
  • Axel Rominger
  • John Seibyl
  • Julia Sauerbeck
  • Marcus Högenauer
  • Matthias Brendel
  • Peter Bartenstein

Organizations

  • AkzoNobel
  • Alzheimer's Drug Discovery Foundation
  • Association France Alzheimer
  • BioClinica
  • Canadian HIV Trials Network, Canadian Institutes of Health Research
  • China Tobacco Guangxi Industrial (China)
  • Chiron Corporation
  • Eli Lilly and Company
  • Foundation for the National Institutes of Health
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Medpace
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense